Market value tracking: ImmuLogic (IMUL)

The chart shows the weekly change in the indexed market value of ImmuLogic Pharmaceutical Corp. (IMUL, dotted line with triangles) compared to The Carson Life Sciences Index of 190 smaller cap companies (<$500M, solid line with squares). The initial index value is 100 as of Dec. 31, 1993. IMUL, which reported positive results in a Phase II/III study of Allervax Ragweed, closed the week at $19, up $1. Its market cap is about $378 million.